NI
PFE icon

NCP Inc’s Pfizer PFE Stock Holding History

NCP Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-391
Closed -$9.76K – 140
2025
Q4 		$9.76K Buy
+391
New +$9.86K 0.01% 126
2025
Q2 		– Sell
-380
Closed -$9.63K – 108
2025
Q1 		$9.63K Buy
380
+3
+0.8% +$79 0.01% 108
2024
Q4 		$9.98K Buy
377
+4
+1% +$108 0.01% 106
2024
Q3 		$10.8K Buy
373
+3
+0.8% +$88 0.01% 101
2024
Q2 		$10.3K Buy
370
+3
+0.8% +$83 0.01% 103
2024
Q1 		$10.2K Buy
+367
New +$10.2K 0.01% 104

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

NCP Inc's PFE Position: Q1 2026 in Review

NCP Inc sold out of Pfizer (PFE) in Q1 2026, closing a stake of 391 shares — an estimated $9.76K sold.

NCP Inc first reported a position in PFE in Q1 2024 and held it in 6 quarters. The position peaked at $10.8K in Q3 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • NCP Inc reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • NCP Inc sold 391 Pfizer shares in Q1 2026, an estimated $9.76K.
  • NCP Inc first reported a position in Pfizer in Q1 2024 and held it in 6 quarters.
  • NCP Inc's Pfizer position peaked at $10.8K in Q3 2024.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on NCP Inc's 13F filing for Q1 2026, filed 8 May 2026.